Beth Israel Deaconess Medical Center, Harvard Medical School is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Beth Israel Deaconess Medical Center, Harvard Medical School has participated in 6 clinical trials with 1 currently active.
Therapeutic areas: Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Heart Failure.
Sponsors: Daiichi Sankyo, Beth Israel Deaconess Medical Center, University of Sao Paulo.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Beth Israel Deaconess Medical Center, Harvard Medical School has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Beth Israel Deaconess Medical Center, Harvard Medical School has 6 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor, Heart Failure.
Yes — Beth Israel Deaconess Medical Center, Harvard Medical School holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.